Cargando…
Celastrol Alleviates Chronic Obstructive Pulmonary Disease by Inhibiting Cellular Inflammation Induced by Cigarette Smoke via the Ednrb/Kng1 Signaling Pathway
Chronic obstructive pulmonary disease (COPD) is a debilitating disease caused by chronic exposure to cigarette smoke (CS). Celastrol is a pentacyclic triterpenoid compound exhibits potent antioxidant and anti-inflammatory activities. Also it is presently known to protect against liver damage induced...
Autores principales: | Shi, Ke, Chen, Xi, Xie, Bin, Yang, Sha Sha, Liu, Da, Dai, Gan, Chen, Qiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249343/ https://www.ncbi.nlm.nih.gov/pubmed/30498444 http://dx.doi.org/10.3389/fphar.2018.01276 |
Ejemplares similares
-
Celastrol Alleviates Airway Hyperresponsiveness and Inhibits Th17 Responses in Obese Asthmatic Mice
por: Zeng, Zeyu, et al.
Publicado: (2018) -
Identifying the Effect of Celastrol Against Ovarian Cancer With Network Pharmacology and In Vitro Experiments
por: Wang, Xuan, et al.
Publicado: (2022) -
Celastrol Alleviates Autoimmune Hepatitis Through the PI3K/AKT Signaling Pathway Based on Network Pharmacology and Experiments
por: Wang, Shuhui, et al.
Publicado: (2022) -
Nanotechnology-Based Celastrol Formulations and Their Therapeutic Applications
por: Wagh, Pushkaraj Rajendra, et al.
Publicado: (2021) -
The therapeutic potential of triptolide and celastrol in neurological diseases
por: Cui, Yueran, et al.
Publicado: (2022)